All TF families have been linked to the disease but more importantly, for example JunB (bZIP) has previously been shown to be essential for proliferation, survival and drug resistance of multiple myeloma and for the treatment of this disease where BTZ was initially developed13. This evidence concerns the gene JUNB and plasma cell myeloma.